Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 64Head & Neck 28Thoracic 19Other solid neoplasm 11Tumor-Agnostic 5Gynecologic 3CNS 3Breast 3Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

venetoclax 193Cyclophosphamide 124Azacitidine 113Cytarabine 108fludarabine 92Specimen Handling 73Biopsy 54Daunorubicin 43Methotrexate 40Dexamethasone 37Rituximab 34blinatumomab 33Vincristine 31Decitabine 31fludarabine phosphate 30Injections 29Granulocyte Colony-Stimulating Factor 28Magnetic Resonance Spectroscopy 27Whole-Body Irradiation 26obinutuzumab 25Idarubicin 25acalabrutinib 23Mycophenolic Acid 23Prednisone 22Melphalan 21Busulfan 21gilteritinib 19Stem Cell Transplantation 19Doxorubicin 19ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cetuximab × Other hematologic neoplasm × Clear all
NCT06447987 2025-12-17

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Recruiting
24 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡